GLP-1 drugs such as Ozempic may offer benefits beyond diabetes and weight loss. A new genetic study links these medicines to ...
Rezolute, Inc. ( RZLT) has completed enrollment in its Phase 3 upLIFT study evaluating ersodetug in tumor hyperinsulinism, a rare condition that can cause severe and persistent low blood sugar. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results